Improving Ischemic Outcomes in ACS: Lessons and Case Discussions from the Experts is organized by C3-Interventional Academy.
Release Date: Mar 01, 2020
Expiration Date: Apr 30, 2020
This activity is intended for attendees of C3 Annual Meeting and other clinicians: interventional cardiologists, cardiologists, vascular surgeons, cardiothoracic surgeons, primary care physicians, technologists and nurses who manage thrombotic risks across diverse patient populations.
Ciné-Med outlined this abiding material for a maximum of 2 AMA PRA Category 1Credit(s)™. Physicians can claim the credit commensurate based on the extent of their participation in the activity
At the conclusion of the session, participants will be able to,
• Review the newest guidelines for antiplatelet therapy in ACS
• Explain the impact of oral antiplatelet therapy on Cardiovascular Mortality in ACS
• Explain the latest efficacy and safety data of antiplatelet therapies for patients undergoing PCI
• Examine the advantages and challenges of managing longer-term antiplatelet therapy for reduction of cardiovascular risk
Additional details will be posted as soon as information is available.
Cardiology, Vascular Surgery